danthron has been researched along with Psoriasis in 9 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Danthrone was inactive." | 1.29 | Down-regulation of epidermal growth factor receptors by dithranol. ( Arenberger, P; Kemény, L; Michel, G; Ruzicka, T, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, K | 3 |
| Prinz, H | 1 |
| Gawlik, I | 1 |
| Ziereis, K | 1 |
| Huang, HS | 1 |
| Reindl, H | 2 |
| Breu, K | 2 |
| Bedord, CJ | 1 |
| Young, JM | 1 |
| Wagner, BM | 1 |
| Schaltegger, A | 1 |
| Bloch, U | 1 |
| Krebs, A | 1 |
| Kemény, L | 2 |
| Michel, G | 1 |
| Arenberger, P | 2 |
| Ruzicka, T | 2 |
| Gross, E | 1 |
| Taskinen, J | 1 |
| Haarala, J | 1 |
| Wartiovaara, E | 1 |
| Halmekoski, J | 1 |
| Wiegrebe, W | 1 |
| Plumier, E | 1 |
| Mayer, KK | 1 |
| Runne, U | 1 |
| Schultz-Amling, W | 1 |
| Rosmarinowski, J | 1 |
| Safar, GJ | 1 |
| Kubka, KD | 1 |
9 other studies available for danthron and Psoriasis
| Article | Year |
|---|---|
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non | 1997 |
Heterocyclic substituted anthralin derivatives as inhibitors of keratinocyte growth and inducers of differentiation.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Differentiation; Cell Division; C | 2001 |
Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
Topics: Acetanilides; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Divis | 2001 |
Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro.
Topics: Animals; Anthracenes; Anthralin; Anthraquinones; Arachidonate Lipoxygenases; Arachidonic Acid; Arach | 1983 |
On the stability of some antipsoriatic active anthralin (dithranol) derivatives.
Topics: Anthracenes; Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Chromatography, High Pressure | 1982 |
Down-regulation of epidermal growth factor receptors by dithranol.
Topics: Anthralin; Anthraquinones; Cell Line; Dose-Response Relationship, Drug; Epidermis; ErbB Receptors; H | 1993 |
Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Anthralin; Anthraquinones; Cell Line; Down-Regulation; E | 1991 |
Oxidation of antipsoriatic 10-acyldithranol derivatives and dithranol to 1,8-dihydroxyanthraquinone.
Topics: Anthralin; Anthraquinones; Chemical Phenomena; Chemistry; Magnetic Resonance Spectroscopy; Oxidation | 1988 |
Experimental contribution to the dithranol-brown problem.
Topics: Anthracenes; Anthralin; Anthraquinones; Hot Temperature; Humans; Mass Spectrometry; Psoriasis; Skin | 1985 |